National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.
about
Surveillance of bloodstream infections in pediatric cancer centers - what have we learned and how do we move on?National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group ReportLate effects of blood and marrow transplantation.Approaches for the prevention of graft-versus-host disease following hematopoietic cell transplantationVitamin D levels and their associations with survival and major disease outcomes in a large cohort of patients with chronic graft-vs-host disease.How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantationNational Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.Verification of the new grading scale for ocular chronic graft-versus-host disease developed by the German-Austrian-Swiss consensus conference on chronic GVHD.Potential of glycosylation research in graft versus host disease after allogeneic hematopoietic stem cell transplantation.Clinical management of genital chronic GvHD.Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care.What do we need to know about allogeneic hematopoietic stem cell transplant survivors?National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report.Classification systems for chronic graft-versus-host disease.Mechanistic approaches for the prevention and treatment of chronic GVHD.Treatment of oral mucosal manifestations of chronic graft-versus-host disease: dexamethasone vs. budesonide.A review of infectious complications after haploidentical hematopoietic stem cell transplantations.Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant ConsortiumCutaneous Graft-Versus-Host Disease: Diagnosis and Treatment.Pulmonary Clinicopathological Correlation after Allogeneic Hematopoietic Stem Cell Transplantation: An Autopsy Series.Characterization and Risk Factor Analysis of Osteoporosis in a Large Cohort of Patients with Chronic Graft-versus-Host Disease.Oral chronic GVHD outcomes and resource utilization: a subanalysis from the chronic GVHD consortium.Morbidity and Mortality Differences Between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors.Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.Chronic graft-vs-host disease in 2016: a major challenge and an opportunity.Psoriasiform graft-versus-host disease distributed along Blaschko's lines.Fungal Prophylaxis with a Gastro-Resistant Posaconazole Tablet for Patients with Hematological Malignancies in the POSANANTES Study.Risk factors for cefepime nonsusceptible Gram-negative infections in allogeneic hematopoietic cell transplant recipients.Decreased pulmonary function in asymptomatic long-term survivors after allogeneic hematopoietic stem cell transplant.Immunohistopathological characterization and the impact of topical immunomodulatory therapy in oral chronic GVHD: a pilot study.Palliative care during and following allogeneic hematopoietic stem cell transplantation.Identification of oral risk factors for chronic graft versus host disease in haematological patients who underwent allogeneic haematopoietic stem cell transplantation.Therapeutic efficiency of platelet gel for the treatment of oral ulcers related to chronic graft versus host disease after allogeneic haematopoietic stem cell transplantation.
P2860
Q26747635-B871C491-0F66-431B-ABCF-6D1DAD33B66CQ26827651-8D29C8DA-E552-4251-9ACF-B0C2D84CA033Q33574136-B5A3718E-FB47-45A0-B55F-CF8D044C7EF7Q36891433-2A8C42DF-9F22-4811-B53A-4C55E0B47A35Q37075994-6501EBD3-F2AB-4C3C-9521-9028FB0ECB33Q37609903-71B0DB15-D036-4811-8957-C2683B365920Q38405199-38C3170D-FAA5-4E0D-BB5C-B7B58442CEA5Q38667029-45132398-1388-451C-8367-153687156AC8Q38753771-E2A39455-D8F8-4C34-822B-5552D5E78C68Q38772931-5BA2750C-8210-4F55-940D-1F0BD4B2970AQ38798042-F32432A2-0E73-4A60-82D8-7D287516E403Q38804386-80BFF323-690C-4FB0-8CC0-1F5FD727A39BQ38808511-355FA1DE-FA98-4FA1-82F3-83C72ED225D2Q39002161-64AF24EE-7A27-4DD0-832D-A3D746F2E0D0Q39002166-9B0B6729-9CA0-4A5D-8CF4-03210255F76AQ39084186-C01F8A79-E0F4-45D9-ADE5-08E82FF9121CQ39247468-1CD5D902-E160-4E21-B985-814C15867F09Q39289010-14EE3DDF-3C99-4AA1-83E4-5567FBE5A100Q39401817-2E63BA17-0944-4E4F-9156-00F5FB7B04B0Q39408929-039D5E1B-4016-4F09-B7C0-9AB129811E0EQ39818593-EBC8C679-4E65-4F7E-B77F-F661CB5F07D1Q40167307-537B543D-CE06-421B-B15B-3526777E6870Q40442400-C00A4290-98D2-42AE-BA64-9C97887F9896Q42768766-E5BDA243-6C91-4BE6-A307-8BE2D3881320Q42943825-CDA47A73-7097-44E1-80A6-68114B3C23DAQ45062605-1D99C3B4-3721-4B50-A3ED-0AAAE84319E4Q47580986-C0527BC8-635D-4FAC-B39E-1CF9619C45D8Q47917729-090F37ED-6748-48AA-81BE-F1DFEA05D8ECQ47930300-708FC094-B765-4EC7-8CDE-5C086B2C76C6Q49350557-E73CABCA-BEB0-4B8E-AF8E-DF09A3FD0731Q50173239-F8857D86-F8E9-4719-91B8-0B5772A390EDQ52717341-6C5A837E-27DF-4FAA-AA59-7D82DEDBC0D2Q55183614-1AA15788-71BC-4A7E-AB0B-B6FACA21FBF6
P2860
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
National Institutes of Health ...... ive Care Working Group Report.
@ast
National Institutes of Health ...... ive Care Working Group Report.
@en
type
label
National Institutes of Health ...... ive Care Working Group Report.
@ast
National Institutes of Health ...... ive Care Working Group Report.
@en
prefLabel
National Institutes of Health ...... ive Care Working Group Report.
@ast
National Institutes of Health ...... ive Care Working Group Report.
@en
P2093
P2860
P1476
National Institutes of Health ...... ive Care Working Group Report.
@en
P2093
Anita Lawitschka
Anthony W Opipari
Bipin N Savani
Carrie L Kitko
Daniel R Couriel
Flora Hoodin
George B McDonald
Georgia B Vogelsang
Juan C Gea-Banacloche
Jörg P Halter
P2860
P304
P356
10.1016/J.BBMT.2015.03.024
P577
2015-03-31T00:00:00Z